Advil Pain Relief Drugmaker Haleon Begins £185M Buyback
Haleon PLC launched a share buyback program on Thursday of up to £185 million ($237 million) as the consumer healthcare giant moves to reduce outstanding share capital....To view the full article, register now.
Already a subscriber? Click here to view full article